Inhibition of the ER stress-PGC-1α pathway significantly blocked the stimulatory activity of cisplatin on HBV replication both in HBV-replicative hepatoma cells and in HBV-transgenic mouse model. The gene discussed is PPARGC1A; the disease is hepatocellular carcinoma.